Amicus Therapeutics Inc. buy Cantor Fitzgerald
Start price
15.01.25
/
50%
€9.00
Target price
15.01.26
€20.29
Performance (%)
-7.22%
Price
09.12.25
€8.40
Summary
This prediction is currently active. With a performance of -7.22%, the BUY prediction for Amicus Therapeutics Inc. by Cantor_Fitzgerald is down slightly. This prediction currently runs until 15.01.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amicus Therapeutics Inc. | 0.599% | 0.599% |
| iShares Core DAX® | 1.659% | 1.586% |
| iShares Nasdaq 100 | 0.381% | 1.900% |
| iShares Nikkei 225® | 2.102% | -1.377% |
| iShares S&P 500 | 0.221% | 1.258% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $21.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.00
07.11.24
07.11.24
€19.47
07.11.25
07.11.25
-24.00%
08.11.25
08.11.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.00
20.09.24
20.09.24
€17.90
20.09.25
20.09.25
-29.50%
21.09.25
21.09.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.80
29.02.24
29.02.24
€20.36
28.02.25
28.02.25
-24.15%
01.03.25
01.03.25